Jump to content

Effectiveness and safety of Moderna COVID-19 vaccine confirmed, path cleared for expected authorization this week


Recommended Posts

Posted

Vaccine maker Moderna is poised to win authorization for its COVID-19 vaccine days after Pfizer-BioNTech did the same.

Data released Tuesday by the U.S. Food and Drug Administration confirmed that Moderna's vaccine appeared safe and highly effective in a study of more than 30,000 volunteers. 

 

Unlike Pfizer-BioNTech's vaccine, Moderna's will be given only to adults. The company has begun testing in teenagers but has not accumulated enough data to include in its authorization request to the FDA. 

An independent advisory committee to the FDA will review the data in an all-day meeting Thursday. If the Vaccines and Related Biological Products Advisory Committee decides that the vaccine's benefits outweigh its risks, the vaccine is likely to be authorized this week by the FDA commissioner.

An independent advisory committee to the U.S. Centers for Disease Control and Prevention will review the data this weekend and will vote on whether to add the vaccine to the nation's vaccine schedule for adults.

Then, as with Pfizer-BioNTech's vaccine, it will be distributed across the country, probably starting Monday.

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...